Effects of paricalcitol on calcium and phosphate metabolism and markers of bone health in patients with diabetic nephropathy: results of the VITAL study
Main Authors: | Coyne, Daniel W., Andress, Dennis L., Amdahl, Michael J., Ritz, Eberhard, de Zeeuw, Dick |
---|---|
Format: | Online |
Language: | English |
Published: |
Oxford University Press
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769981/ |
Similar Items
-
Oral Paricalcitol for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease
by: Cheng, Steven, et al.
Published: (2006) -
Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study
by: Ketteler, Markus, et al.
Published: (2012) -
Ethnic differences in calcium, phosphate and bone metabolism
by: Redmond, J., et al.
Published: (2014) -
Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients
by: Izquierdo, María Jesús, et al.
Published: (2012) -
Antiapoptotic Effect of Paricalcitol in Gentamicin-induced Kidney Injury
by: Suh, Sang Heon, et al.
Published: (2013)